Concepedia
3
Publications
106
Citations
H-Index
2021
Active since
Affiliations
Roche (Switzerland)(Current)
University of Basel
Gabrielle Leclercq-Cohen is an author at Roche (Switzerland).
Publications per year
2021–2023
Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies
Gabrielle Leclercq-Cohen, Hélène Haegel, Anneliese Schneider et al. · Journal for ImmunoTherapy of Cancer · 2021 · 39 citations · Full text
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies
Gabrielle Leclercq-Cohen, Nathalie Steinhoff, Llucia Albertí Servera et al. · Clinical Cancer Research · 2023 · 38 citations · Full text
JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy
Gabrielle Leclercq-Cohen, Hélène Haegel, Alberto Toso et al. · Journal for ImmunoTherapy of Cancer · 2022 · 29 citations · Full text
Rows per page
1–3 of 3